By Shalini Bhardwaj

New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged 5-12, said sources on Thursday.

Also Read | Congress Leader Sachin Pilot Meets Party Chief Sonia Gandhi In Delhi Amid Ongoing Deliberations on Future Strategy.

The Corbevax is currently being administered to children in the age group of 12-14.

COVID-19 vaccinations for minors in India was started from January 3 onwards with those in the 15-18 age group for BharatBiotech's Covaxin.

Also Read | Uttar Pradesh CM Yogi Adityanath Directs Officials To Focus on Children's Health Amid Rise in COVID-19 Cases.

The drive later expanded on March 16 to include children aged above 12 for Corbevax.

Overall India is currently administering two COVID-19 vaccines for children above 12.(ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)